Search Results - "Mikusova, Katarina"

Refine Results
  1. 1

    DprE1--from the discovery to the promising tuberculosis drug target by Mikusová, Katarína, Makarov, Vadim, Neres, João

    Published in Current pharmaceutical design (01-01-2014)
    “…Several groups working in the field of the development of new antituberculosis drugs have recently reported active compounds targeting mycobacterial enzyme…”
    Get more information
    Journal Article
  2. 2

    Galactosyl Transferases in Mycobacterial Cell Wall Synthesis by BELANOVA, Martina, DIANISKOVA, Petronela, BRENNAN, Patrick J, COMPLETO, Gladys C, ROSE, Natisha L, LOWARY, Todd L, MIKULOVH, Katarina

    Published in Journal of Bacteriology (01-02-2008)
    “…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  3. 3

    Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors by Sabbah, Mohamad, Mendes, Vitor, Vistal, Robert G, Dias, David M. G, Záhorszká, Monika, Mikušová, Katarína, Korduláková, Jana, Coyne, Anthony G, Blundell, Tom L, Abell, Chris

    Published in Journal of medicinal chemistry (14-05-2020)
    “…Tuberculosis (TB) remains a leading cause of mortality among infectious diseases worldwide. InhA has been the focus of numerous drug discovery efforts as this…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents by Hajian, Behnoush, Scocchera, Eric, Shoen, Carolyn, Krucinska, Jolanta, Viswanathan, Kishore, G-Dayanandan, Narendran, Erlandsen, Heidi, Estrada, Alexavier, Mikušová, Katarína, Korduláková, Jana, Cynamon, Michael, Wright, Dennis

    Published in Cell chemical biology (20-06-2019)
    “…The folate biosynthetic pathway offers many druggable targets that have yet to be exploited in tuberculosis therapy. Herein, we have identified a series of…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents by Fan, Dongguang, Wang, Bin, Stelitano, Giovanni, Savková, Karin, Shi, Rui, Huszár, Stanislav, Han, Quanquan, Mikušová, Katarína, Chiarelli, Laurent R, Lu, Yu, Qiao, Chunhua

    Published in Journal of medicinal chemistry (14-10-2021)
    “…The benzothiazinone (BTZ) scaffold compound PBTZ169 kills by inhibiting the essential flavoenzyme DprE1, consequently blocking the synthesis of the cell wall…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Compartmentalization of galactan biosynthesis in mycobacteria by Savková, Karin, Danchenko, Maksym, Fabianová, Viktória, Bellová, Jana, Bencúrová, Mária, Huszár, Stanislav, Korduláková, Jana, Siváková, Barbara, Baráth, Peter, Mikušová, Katarína

    Published in The Journal of biological chemistry (01-03-2024)
    “…Galactan polymer is a prominent component of the mycobacterial cell wall core. Its biogenesis starts at the cytoplasmic side of the plasma membrane by a…”
    Get full text
    Journal Article
  13. 13

    Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents by Liu, Lingfeng, Kong, Chengcheng, Fumagalli, Marco, Savková, Karin, Xu, Yiwen, Huszár, Stanislav, Sammartino, José C., Fan, Dongguang, Chiarelli, Laurent R., Mikušová, Katarína, Sun, Zhaogang, Qiao, Chunhua

    Published in European journal of medicinal chemistry (15-12-2020)
    “…Decaprenylphosphoryl-β-d-ribose 2′-oxidoreductase (DprE1) is a promising drug target for the development of novel anti-tubercular agents, and inhibitors of…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Copper-related toxicity in replicating and dormant Mycobacterium tuberculosis caused by 1-hydroxy-5-R-pyridine-2(1H)-thiones by Salina, Elena G, Huszár, Stanislav, Zemanová, Júlia, Keruchenko, Jan, Riabova, Olga, Kazakova, Elena, Grigorov, Artyom, Azhikina, Tatyana, Kaprelyants, Arseny, Mikušová, Katarína, Makarov, Vadim

    Published in Metallomics (18-07-2018)
    “…With the emerging primary resistance of Mycobacterium tuberculosis to current drugs and wide distribution of latent tuberculosis infection, the need for new…”
    Get full text
    Journal Article
  18. 18

    Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043 by Tiwari, Rohit, Miller, Patricia A, Chiarelli, Laurent R, Mori, Giorgia, Šarkan, Michal, Centárová, Ivana, Cho, Sanghyun, Mikušová, Katarína, Franzblau, Scott G, Oliver, Allen G, Miller, Marvin J

    Published in ACS medicinal chemistry letters (10-03-2016)
    “…Electron deficient nitroaromatic compounds such as BTZ043 and its closest congener, PBTZ169, and related agents are a promising new class of anti-TB compounds…”
    Get full text
    Journal Article
  19. 19

    The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis by Makarov, Vadim, Neres, João, Hartkoorn, Ruben C, Ryabova, Olga B, Kazakova, Elena, Šarkan, Michal, Huszár, Stanislav, Piton, Jérémie, Kolly, Gaëlle S, Vocat, Anthony, Conroy, Trent M, Mikušová, Katarína, Cole, Stewart T

    Published in Antimicrobial agents and chemotherapy (01-08-2015)
    “…8-Nitro-benzothiazinones (BTZs), such as BTZ043 and PBTZ169, inhibit decaprenylphosphoryl-β-d-ribose 2'-oxidase (DprE1) and display nanomolar bactericidal…”
    Get full text
    Journal Article
  20. 20

    GtrA Protein Rv3789 Is Required for Arabinosylation of Arabinogalactan in Mycobacterium tuberculosis by Kolly, Gaëlle S, Mukherjee, Raju, Kilacsková, Emöke, Abriata, Luciano A, Raccaud, Mahé, Blaško, Jaroslav, Sala, Claudia, Dal Peraro, Matteo, Mikušová, Katarína, Cole, Stewart T

    Published in Journal of bacteriology (01-12-2015)
    “…Mycobacterium tuberculosis possesses a thick and highly hydrophobic cell wall principally composed of a mycolyl-arabinogalactan-peptidoglycan complex, which is…”
    Get full text
    Journal Article